1 minute read
SCHOOL LAUNCHES NEW DEGREE
STUDENTS
SCHOOL LAUNCHES NEW DEGREE IN BIOPHARMACEUTICAL MARKETING
The first-of-its-kind Master of Science in Biopharmaceutical Marketing (BPMK) builds core knowledge and strategic skills for success in the dynamic biopharmaceutical industry. It confers expertise in areas such as emerging devices and diagnostics, product development and marketing, strategies for healthcare coverage and reimbursement, and integration of pricing and business intelligence.
The newly launched, interdisciplinary BPMK degree provides advantages to students who are entering healthcareindustry careers, as well as for busy professionals who want to boost their experience.
“Biopharmaceuticals are the fastest-growing segment of the healthcare industry,” says Ken S. Wong, director of the BPMK and Healthcare Decision Analysis programs.
BPMK faculty members combine professional and practical expertise using novel academic methods to prepare students for meeting those future challenges.
“I was attracted to this program for the interdisciplinary curriculum and the hands-on approach,” says first-year master’s student Nina Hu. “After graduating as a biochemistry major from UCLA, I wanted to find a program that would help me transition between science and business, and this program was a perfect match. It’s an amazing program for people who are interested in the pharmaceutical industry and want hands-on experience.”
The accelerated 27-unit BPMK can be completed in as few as three concentrated semesters. The curriculum combines classroom lectures and scenario-based learning exercises that develop real-world experience utilizing the mentorship of working industry professionals.
“This new master’s degree exemplifies the School of Pharmacy’s dedication to widening the scope of professional opportunities for our students, while keeping ahead of evolving trends in the healthcare industry,” Dean Vassilios Papadopoulos says.
Nina Hu, MS Class of 2022
